Enliven Therapeutics, Inc. logo ELVN - Enliven Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 9
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $76.00 DETAILS
HIGH: $82.00
LOW: $65.00
MEDIAN: $78.00
CONSENSUS: $76.00
UPSIDE: 27.05%
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1
Revenue
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 0 0.0 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0.0 0 0 0 0 0 0 0 0
Gross Profit 0 (0.0) (0.0) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.0) (0.0) (0.0) 0 0 0 0 0 0 0 0
Operating Expenses
R&D Expenses 29.0 20.7 21.2 18.2 21.5 24.9 20.7 21.3 18.8 20.0 17.9 19.6 15.2 11.9 8.2 7.8 7.9 7.1 6.9 10.4 10.1 7.1 9.0 9.5 7.9 5.8 5.9 5.1 4.4 3.6
SG&A Expenses 8.2 7.1 13.0 6.9 7.1 6.8 6.2 5.8 5.8 6.0 4.8 3.3 3.7 4.5 2.0 3.1 1.1 1.6 1.5 3.2 3.1 3.1 2.6 3.0 2.4 1.6 1.5 1.7 1.2 0.6
Other Expenses 0 0 0 0 0 0 0 0 0 0 0 1.3 1.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses 37.2 27.8 34.2 25.1 28.6 31.7 26.9 27.1 24.6 26.0 22.7 24.2 20.1 16.4 10.2 10.9 9.0 8.7 8.4 13.6 13.1 10.3 11.6 12.5 10.3 7.4 7.5 6.9 5.6 4.2
Operating Income
Operating Income (37.2) (27.8) (34.3) (25.1) (28.6) (31.7) (26.9) (27.1) (24.6) (26.0) (22.7) (24.2) (20.1) (16.4) (10.2) (10.9) (9.0) (8.7) (8.4) (13.7) (13.2) (10.3) (11.6) (12.5) (10.3) (7.4) (7.5) (6.9) (5.6) (4.2)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest Income 4.7 4.2 4.6 4.9 3.3 3.2 3.7 3.8 4.1 3.2 3.4 3.5 3.4 1.7 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.2 0
Profitability
EBITDA (32.5) (23.6) (29.6) (20.1) (25.3) (28.5) (23.1) (23.1) (19.6) (22.7) (19.3) (20.7) (16.6) (14.7) (9.5) (10.5) (8.8) (8.6) (8.4) (13.6) (13.1) (10.2) (11.5) (12.4) (10.2) (7.2) (7.2) (6.6) (5.4) (4.2)
EBIT (32.5) (23.6) (29.7) (20.1) (25.3) (28.5) (23.2) (23.2) (19.7) (22.7) (19.4) (20.8) (16.7) (14.7) (9.6) (10.6) (8.9) (8.7) (8.4) (13.6) (13.2) (10.3) (11.5) (12.4) (10.2) (7.2) 0 (6.6) (5.6) (4.2)
Income Before Tax (32.5) (23.6) (29.7) (20.1) (25.3) (28.5) (23.2) (23.2) (19.7) (22.7) (19.4) (20.8) (16.7) (14.7) (9.6) (10.6) (8.9) (8.7) (8.4) (13.6) (13.2) (10.3) (11.5) (12.4) (10.2) (7.2) (7.2) (6.6) (5.4) (4.2)
Income Tax Expense 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.0)
Net Income (32.5) (23.6) (29.7) (20.1) (25.3) (28.5) (23.2) (23.2) (19.9) (22.7) (19.4) (20.8) (16.7) (14.7) (9.6) (10.6) (8.9) (8.7) (8.4) (13.6) (13.2) (10.3) (11.5) (12.4) (10.2) (7.2) (7.2) (6.6) (5.4) (4.2)
Per Share Data
EPS (Basic) -0.49 -0.38 -0.45 -0.32 -0.49 -0.57 -0.46 -0.48 -0.41 -0.54 -0.47 -0.51 -0.41 -0.80 -1.45 -0.70 -1.74 -2.23 -2.18 -2.19 -2.97 -2.33 -2.63 -2.86 -2.37 -3.64 -1.68 -1.53 -1.25 -0.97
EPS (Diluted) -0.49 -0.38 -0.45 -0.32 -0.49 -0.57 -0.46 -0.48 -0.41 -0.54 -0.47 -0.51 -0.41 -0.80 -1.45 -0.70 -1.74 -2.23 -2.18 -2.19 -2.97 -2.33 -2.63 -2.86 -2.37 -3.64 -1.68 -1.53 -1.25 -0.97
Shares Outstanding 66.2 62.8 56.7 62.1 52.1 50.1 49.9 48.3 48.1 42.0 41.1 41.0 41.0 18.5 6.6 6.6 6.6 6.6 6.6 6.2 4.4 4.4 4.4 4.3 4.3 4.1 4.3 4.3 4.3 4.3
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4
Current Assets
Cash & Cash Equivalents 135.5 132.2 98.9 101.7 119.4 101.7 124.1 100.6 96.9 149.2 100.1 73.8 125.7 292.1 75.5 86.2 30.4 36.5 110.0 75.3 48.0 53.4 47.7 34.2 54.7 86.7 4.9
Short-Term Investments 759.6 320.2 363.7 375.8 371.1 187.8 189.3 191.2 215.5 171.3 153.0 189.6 152.2 0 0 0 29.9 36.4 0 27.5 18.7 22.2 40.5 61.9 51.6 19.1 24.0
Net Receivables 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 0 10.7 12.3 5.1 0 4.8 4.7 0.1 5.7 10.1 10.1 0 0 5.9 2.2 0 3.9 5.6 0 3.2 4.6 4.8 2.2 3.6 4.3 3.9 1.7
Total Current Assets 907.3 463.1 474.9 482.7 495.6 294.3 318.1 297.0 318.1 337.2 266.2 268.6 283.2 298.0 77.8 88.2 64.3 78.5 110.7 106.0 71.4 80.4 90.4 99.7 110.6 109.8 30.6
Non-Current Assets
Property, Plant & Equipment 1.6 0.3 0.4 0.9 1.0 1.1 0.5 0.6 0.8 0.9 1.1 1.2 1.3 1.4 1.5 1.6 0.2 2.9 1.0 0.9 0.9 1.0 0.3 0.4 0.4 0.4 0.4
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0.1 0 0.2 0.2 0 0.2 0.2 0.1 0 0 0 0 0
Other Non-Current Assets 1.2 1.4 0.9 7.3 7.2 7.2 7.2 7.8 8.1 4.7 4.7 4.2 4.0 3.4 4.0 1.0 (0.0) (0.0) 1.7 0 0 0.2 0.1 0.1 0.3 0.1 2.2
Total Non-Current Assets 2.9 1.7 1.3 8.2 8.3 8.3 7.6 8.4 8.9 5.6 5.7 5.4 5.3 4.9 5.5 2.6 0.4 3.1 2.7 1.0 1.1 1.3 0.4 0.5 0.7 0.5 2.7
Total Assets 910.2 464.9 476.2 490.9 503.9 302.6 325.8 305.4 327.0 342.8 271.9 274.0 288.5 302.9 83.3 90.8 64.7 81.6 113.3 107.0 72.5 81.7 90.8 100.2 111.3 110.3 33.3
Current Liabilities
Account Payables 0.4 1.6 2.2 1.4 2.4 1.6 1.3 1.0 1.1 2.7 0.5 1.5 2.8 5.9 3.4 3.0 1.1 1.9 2.5 2.5 2.6 3.0 2.0 1.9 1.7 2.3 1.7
Short-Term Debt 0.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0.5 0 0.2 0.3 0.3 0 0 0 0 0
Deferred Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5.5 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 10.2 2.4 4.6 4.0 0.1 2.2 4.8 0.2 11.6 10.4 10.4 0.4 0.7 3.7 0.3 1.1 1.1 3.7 0.2 2.9 3.0 1.6 3.2 2.2 1.9 2.2 2.5
Total Current Liabilities 14.2 11.5 16.6 14.7 15.2 14.0 15.9 17.0 22.1 25.0 25.9 12.1 9.1 10.9 9.7 8.3 3.3 7.2 5.8 7.2 7.0 5.5 6.2 5.3 4.8 4.9 4.2
Non-Current Liabilities
Long-Term Debt 0.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0.1 0 0.3 0 0 0.0 0.0 0.1 0.2 0.4 0.5 150.4 0.8 1.6 0 0.7 0 0 0 0.2 0.2 0 0.2 0.2
Total Non-Current Liabilities 0.9 0 0.1 0.1 0.2 0.3 0 0 0.0 0.0 0.1 0.2 0.4 0.5 150.4 0.8 1.6 2.0 0.7 0.5 0.5 0.6 0.2 0.2 0.2 0.2 0.2
Total Liabilities 15.1 11.5 16.7 14.8 15.4 14.3 15.9 17.0 22.1 25.1 26.0 12.3 9.5 11.4 160.1 9.1 3.3 9.2 6.5 7.7 7.5 6.1 6.4 5.5 5.0 5.1 4.4
Stockholders' Equity
Common Stock 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Retained Earnings (403.3) (370.8) (347.2) (317.5) (297.4) (272.0) (243.5) (220.3) (197.1) (177.2) (154.4) (135.1) (114.3) (97.6) (82.9) (73.3) (173.6) (162.1) (45.2) (133.2) (119.5) (106.4) (96.1) (84.6) (72.2) (62.0) (54.8)
Accumulated Other Comprehensive Income (1.9) (0.4) 0.3 0.2 (0.2) (0.0) 0.1 0.2 (0.1) (0.1) 0.1 (0.1) (0.1) 0 (0.1) 0 (0.0) (0.1) 0 (0.0) 0 0.0 0.0 0.0 0.0 (0.0) 0.0
Total Stockholders' Equity 895.1 453.4 459.6 476.1 488.5 288.3 309.8 288.4 304.9 317.7 245.9 261.7 279.0 291.4 (76.8) 81.7 61.4 72.4 106.9 99.4 65.0 75.6 84.4 94.7 106.3 105.2 28.9
Total Liabilities & Equity 910.2 464.9 476.2 490.9 503.9 302.6 325.8 305.4 327.0 342.8 271.9 274.0 288.5 302.9 83.3 90.8 64.7 81.6 113.3 107.0 72.5 81.7 90.8 100.2 111.3 110.3 33.3
Debt Metrics
Total Debt 1.5 0.3 0.4 0.4 0.6 0.4 0 0.1 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4 2.5 0.2 0.7 0.8 0.8 0 0 0 0 0
Net Debt (134.0) (131.9) (98.5) (101.3) (118.9) (101.3) (124.1) (100.5) (96.7) (148.9) (99.8) (73.5) (125.4) (291.8) (75.2) (85.8) (30.0) (34.0) (109.9) (74.6) (47.3) (52.6) (47.7) (34.2) (54.7) (86.7) (4.9)
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1
Operating Activities
Net Income (32.5) (23.6) (29.7) (20.1) (25.3) (28.5) (23.2) (23.2) (19.9) (22.7) (19.4) (20.8) (16.7) (14.7) (9.6) (10.6) (8.9) (8.7) (14.3) (13.6) (13.2) (10.3) (11.5) (12.4) (10.2) (7.2) (7.2) (6.6) (5.4) (4.2)
Depreciation & Amortization 0.0 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0
Stock-Based Compensation 13.9 7.4 12.3 7.2 7.7 6.8 5.3 5.2 5.1 4.5 3.1 3.4 4.2 2.3 0.7 1.1 0.7 0.7 0 0 0 0 0.7 0.6 0.6 0.4 0.3 0.3 0.2 0.1
Change in Working Capital (0.6) (3.4) 1.2 (0.2) 0.3 (2.5) (0.5) 5.0 (4.4) (4.6) 5.5 3.2 1.2 (8.4) 0.6 1.2 1.0 (2.4) 0.8 1.7 1.8 (3.8) 2.4 1.5 0.4 (2.7) (1.1) 0.0 0.1 1.7
Other Non-Cash Items 0.6 0.1 0.2 (0.2) 0.1 0.0 1.1 0.7 (1.3) (0.6) 2.5 (1.8) (0.8) 0 0 1.7 0 0 1.0 1.0 0.9 1.0 0.2 (0.0) (0.0) 0.0 (0.0) (0.0) 0 0
Operating Cash Flow (18.5) (19.3) (15.8) (13.3) (17.1) (24.1) (17.2) (12.2) (20.4) (23.4) (12.5) (15.9) (12.0) (20.8) (8.1) (6.4) (7.1) (10.4) (12.5) (10.9) (10.4) (13.0) (8.3) (10.3) (9.3) (9.5) (8.0) (6.3) (5.1) (2.4)
Investing Activities
Capital Expenditure (0.1) 0 0 0.0 (0.1) (0.0) 0 (0.0) (0.0) (0.0) (0.0) (0.0) (0.1) (0.0) (0.1) (0.0) (0.3) (0.2) 0 0 0 (0.0) 0.0 0 (0.0) (0.0) 0 (0.1) (0.1) 0
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 (40) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (560.2) (65.8) (75.5) (71.9) (240.2) (59.2) (116.5) (234.2) (120.8) (56.8) (41.3) (75.5) (151.4) 0 0 0 0 0 (17.8) (22.2) (3.8) (3.7) (8.4) (14.0) 0 0 (2.1) (21.8) 0 0
Sales/Maturities of Investments 118.7 108.4 87.7 67.8 56.7 60.7 117.2 196.7 77.2 38.9 80 40 0 0 0 0 0 0 3.3 13.4 7.2 22.0 29.6 3.7 9.4 4.8 0 0 0 0
Other Investing Activities 0 0 0.2 0 0 0 0 52.4 10 0 0 40 0 0 0 0 0 0 0 0 0 0 0 0 (41.8) 0 0 0 0 0
Investing Cash Flow (441.6) 42.5 12.4 (4.1) (183.6) 1.4 0.7 14.8 (33.7) (17.9) 38.7 (35.5) (151.5) (0.0) (0.1) (0.0) (0.3) (0.2) (14.5) (8.8) 3.4 18.3 21.2 (10.3) (32.4) 4.8 (2.1) (21.9) (0.1) 0
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0.4 0 0 0 0 0 90.5 0 0 0.3 0 0 (1.3) 74.4 (2.4) 0 0 0 0 0 0 0 0 0 0 0 (2.0) 0 1.6 43.9
Financing Cash Flow 463.4 10.1 0.6 (0.4) 218.4 0.2 40.0 1.1 1.8 90.3 0.1 (0.4) (2.8) 237.4 (2.4) 0.2 0.0 0.4 (0.0) 47.0 1.7 0.5 0.6 0.1 9.6 86.6 (2.0) 0 1.6 43.9
Cash Position
Net Change in Cash 3.3 33.3 (2.8) (17.7) 17.7 (22.5) 23.5 3.8 (52.3) 49.0 26.3 (51.9) (166.4) 203.9 (10.6) 19.1 (6.1) (11.8) (27.0) 27.3 (5.4) 5.7 13.5 (20.5) (32.1) 81.8 (12.2) (28.1) (3.6) 41.5
Cash at Beginning 132.2 98.9 101.7 119.4 101.7 124.2 100.7 96.9 149.2 100.2 73.8 125.8 292.1 88.2 86.2 30.4 36.5 48.3 75.3 48.0 53.4 47.7 34.2 54.7 86.8 5.0 17.2 45.3 48.9 7.4
Cash at End 135.5 132.2 98.9 101.7 119.4 101.7 124.2 100.7 96.9 149.2 100.2 73.9 125.7 292.1 75.6 49.5 30.4 36.5 48.3 75.3 48.0 53.4 47.8 34.2 54.7 86.8 5.0 17.2 45.3 48.9
Free Cash Flow (18.6) (19.3) (15.8) (13.3) (17.2) (24.1) (17.2) (12.2) (20.4) (23.4) (12.5) (15.9) (12.1) (20.9) (8.2) (6.5) (7.4) (10.6) (12.5) (10.9) (10.4) (13.0) (8.3) (10.3) (9.3) (9.5) (8.0) (6.3) (5.2) (2.4)
Key Metrics 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1
Income Statement
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 0 (0.0) (0.0) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.0) (0.0) (0.0) 0 0 0 0 0 0 0 0
Operating Income (37.2) (27.8) (34.3) (25.1) (28.6) (31.7) (26.9) (27.1) (24.6) (26.0) (22.7) (24.2) (20.1) (16.4) (10.2) (10.9) (9.0) (8.7) (8.4) (13.7) (13.2) (10.3) (11.6) (12.5) (10.3) (7.4) (7.5) (6.9) (5.6) (4.2)
Net Income (32.5) (23.6) (29.7) (20.1) (25.3) (28.5) (23.2) (23.2) (19.9) (22.7) (19.4) (20.8) (16.7) (14.7) (9.6) (10.6) (8.9) (8.7) (8.4) (13.6) (13.2) (10.3) (11.5) (12.4) (10.2) (7.2) (7.2) (6.6) (5.4) (4.2)
EPS (Diluted) -0.49 -0.38 -0.45 -0.32 -0.49 -0.57 -0.46 -0.48 -0.41 -0.54 -0.47 -0.51 -0.41 -0.80 -1.45 -0.70 -1.74 -2.23 -2.18 -2.19 -2.97 -2.33 -2.63 -2.86 -2.37 -3.64 -1.68 -1.53 -1.25 -0.97
Balance Sheet
Cash & Equivalents 135.5 132.2 98.9 101.7 119.4 101.7 124.1 100.6 96.9 149.2 100.1 73.8 125.7 292.1 75.5 86.2 30.4 36.5 110.0 75.3 48.0 53.4 47.7 34.2 54.7 86.7 4.9
Total Assets 910.2 464.9 476.2 490.9 503.9 302.6 325.8 305.4 327.0 342.8 271.9 274.0 288.5 302.9 83.3 90.8 64.7 81.6 113.3 107.0 72.5 81.7 90.8 100.2 111.3 110.3 33.3
Total Debt 1.5 0.3 0.4 0.4 0.6 0.4 0 0.1 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4 2.5 0.2 0.7 0.8 0.8 0 0 0 0 0
Stockholders' Equity 895.1 453.4 459.6 476.1 488.5 288.3 309.8 288.4 304.9 317.7 245.9 261.7 279.0 291.4 (76.8) 81.7 61.4 72.4 106.9 99.4 65.0 75.6 84.4 94.7 106.3 105.2 28.9
Cash Flow
Operating Cash Flow (18.5) (19.3) (15.8) (13.3) (17.1) (24.1) (17.2) (12.2) (20.4) (23.4) (12.5) (15.9) (12.0) (20.8) (8.1) (6.4) (7.1) (10.4) (12.5) (10.9) (10.4) (13.0) (8.3) (10.3) (9.3) (9.5) (8.0) (6.3) (5.1) (2.4)
Capital Expenditure (0.1) 0 0 0.0 (0.1) (0.0) 0 (0.0) (0.0) (0.0) (0.0) (0.0) (0.1) (0.0) (0.1) (0.0) (0.3) (0.2) 0 0 0 (0.0) 0.0 0 (0.0) (0.0) 0 (0.1) (0.1) 0
Free Cash Flow (18.6) (19.3) (15.8) (13.3) (17.2) (24.1) (17.2) (12.2) (20.4) (23.4) (12.5) (15.9) (12.1) (20.9) (8.2) (6.5) (7.4) (10.6) (12.5) (10.9) (10.4) (13.0) (8.3) (10.3) (9.3) (9.5) (8.0) (6.3) (5.2) (2.4)